Coronavirus antibodies for research

Coronaviruses are large, enveloped, non-segmented positive-sense RNA viruses that affect humans, birds and mammals. The viral genome is approximately 27-30 kb and consists of four structural proteins including Spike, Envelope, Membrane and Nucleocapsid proteins that play an important role in viral synthesis and replication. Due to the COVID-19 pandemic caused by SARS-CoV-2 virus, there is an urgent need to develop antibodies against the coronavirus structural proteins to design treatment strategies to COVID-19.

Coronavirus antibodies for research
A. Western blot analysis using Anti-SARS-CoV-2 Antibody (Clone# 6F10) (Cat.No A2060-50). B. Virus Neutralization Assay using Anti-SARS-CoV-2 Spike S1 Antibody (Cat.No A3000-50).

BioVision is pleased to offer a range of Antibodies that can be used for Coronavirus research. These antibodies specialize in detecting SARS-CoV-2, SARS and MERS Nucleoproteins & Spike proteins. The antibodies have been tested in applications such as Western Blot, ELISA, Immunofluorescence, Immunohistochemistry etc.

Key features:

  • Recognizes SARS-CoV-2, SARS & MERS Nucleoproteins & Spike proteins
  • Research applications include Western blot, IHC, ELISA etc.
  • Available in Monoclonal & Polyclonal formats
  • Ready to ship worldwide

Below are few highlighted Antibodies available from BioVision: Click here to see complete range of COVID-19 Antibodies.

Product Name

Cat. No.


Anti-CoV-2 & SARS-CoV-2 NP Antibody (Clone# 4G1)


50 μg

Anti-CoV-2 & SARS-CoV S1 Antibody (Clone# CR3022)


200 μg

Anti-IL-6 receptor (Tocilizumab), Human IgG1 Antibody


200 µg

Anti-SARS-CoV-2 NP Antibody (Clone# 6F10)


50 µg

Anti-SARS-CoV-2 NP Antibody


50 µg

Anti-SARS-CoV-2 NP Antibody (Clone# 11D5)


50 µg

Anti-SARS-CoV-2 Spike S1 Antibody


50 μg

Anti-SARS-CoV-2 Spike S1 Antibody (Clone# 4C6)


50 μg



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BioVision Incorporated. (2020, May 04). Coronavirus antibodies for research. News-Medical. Retrieved on December 04, 2021 from

  • MLA

    BioVision Incorporated. "Coronavirus antibodies for research". News-Medical. 04 December 2021. <>.

  • Chicago

    BioVision Incorporated. "Coronavirus antibodies for research". News-Medical. (accessed December 04, 2021).

  • Harvard

    BioVision Incorporated. 2020. Coronavirus antibodies for research. News-Medical, viewed 04 December 2021,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.